NCT00003214 2019-05-15
Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
Swiss Cancer Institute
Phase 3 Completed
Swiss Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GOG Foundation